$13.16
0.53% (Daily)
Market Cap
$2.44B
Revenue
$109.23M
Rank by MCap
#1753
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Paul B. Bolno M.B.A., M.D.
Headquarters
Singapore
Employees
287
Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, an RNA editing oligonucleotide for the treatment of alpha-1 ...
Loading chart…